Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell cultureAnna Lahti, Katriina Aalto‐Setälä, Ville Kujala et al.|Disease Models & Mechanisms|2011Cited by 291
A Defined and Xeno-Free Culture Method Enabling the Establishment of Clinical-Grade Human Embryonic, Induced Pluripotent and Adipose Stem CellsKristiina Rajala, Heli Skottman, Susanna Miettinen et al.|PLoS ONE|2010Cited by 165
Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Reveals Early and Delayed AfterdepolarizationsKirsi Kujala, Katriina Aalto‐Setälä, Jere Paavola et al.|PLoS ONE|2012Cited by 135
Cardiac Differentiation of Pluripotent Stem CellsKristiina Rajala, Katriina Aalto‐Setälä, Mari Pekkanen-Mattila|Stem Cells International|2011Cited by 134
Mutation‐Specific Phenotypes in hiPSC‐Derived Cardiomyocytes Carrying Either Myosin‐Binding Protein C Or <i>α</i>‐Tropomyosin Mutation for Hypertrophic CardiomyopathyKatriina Aalto‐Setälä, Chandra Prajapati, Risto-Pekka Pölönen et al.|Stem Cells International|2015Cited by 105